AquaBounty CEO to testify before U.S. Senate subcommittee
Genetically engineered fish issue enters Senate as FDA continues long-running scientific review of AquAdvantage salmon application.
Published 15 December 2011, 13:44Updated 6 May 2016, 10:21
Genetically engineered fish issue enters Senate as FDA continues long-running scientific review of AquAdvantage salmon application.